Ubs Group Ag Lantheus Holdings, Inc. Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
A detailed history of Ubs Group Ag transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 650,644 shares of LNTH stock, worth $35.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
650,644
Previous 238,205
173.14%
Holding current value
$35.7 Million
Previous $23.2 Million
129.1%
% of portfolio
0.01%
Previous 0.0%
Shares
34 transactions
Others Institutions Holding LNTH
# of Institutions
542Shares Held
77.9MCall Options Held
710KPut Options Held
433K-
Black Rock Inc. New York, NY8.6MShares$472 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X06.94MShares$381 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.84MShares$375 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA6.72MShares$369 Million2.47% of portfolio
-
State Street Corp Boston, MA2.56MShares$140 Million0.01% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $3.77B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...